Navigation Links
accretion in Medical News

HRT an accretion of cancer

Researchers from Sweden warn women undergoing hormone replacement therapy against the risk of uterus cancer.// Hormone Replacement Therapy is advised for women to reduce menopausal side effects like hot flushes and night sweats, and to protect them from osteoporosis and heart disease. Re...

Nuvo Announces 2009 second quarter financial results

...d payments 132 216 264 366 Deferred stock unit expense 145 - 239 - accretion of interest on debentures 147 227 295 434 Other (273) 91 ...

Orexigen(R) Therapeutics Announces Second Quarter 2009 Financial Results

... ---- --- ---- ----- ----- Net loss (17,806) (23,113) (37,109) (46,327) (237,284) accretion to redemption value of redeemable convertible preferred stock - - - - (78...

Gen-Probe Reports Financial Results for Second Quarter 2009

...ivities: Depreciation and amortization 19,463 17,233 Amortization of premiums on investments, net of accretion of discounts 2,720 3,504 Stock-based compensation 11,405 9,228 Stock-based compen...

WellPoint Reports Second Quarter 2009 Results

...n disposal of assets 0.9 0.5 Deferred income taxes 18.1 26.0 Amortization, net of accretion 225.0 238.2 Depreciation expense 52.3 51.9 Share-based compensation ...

Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29

...quity components of our convertible notes partially offset by the accretion of the reduced carrying values resulting from the recognition of ...erest expense recognized through December 31, 2008 related to the accretion of the reduced carrying values of our convertible notes and (ii) ...

AIM Health Group Inc. reports largest quarterly profit since going public and announces filing of financial results for the three months ended March 31, 2009 on SEDAR

...d 272 (32) (1) EBITDA is defined as earnings before interest, taxes and non-cash items including stock compensation and accretion expenses. The Company went on to advise that the integration of the MedEmerg service lines continues. Two of MedEmerg's chronic pain management ...

BELLUS Health reports results for first quarter of fiscal 2009

...ompared to the same period the previous year. accretion expense amounted to $1,282,000 for the current qua...$1,207,000 for the same quarter the previous year. accretion expense represents the imputed interest under GAAP...imited to: all debt would be presented as current, accretion on convertible notes would be accelerated, and the...

Triple-S Management Corporation Reports First Quarter 2009 Results

...its current Board authorization. 2009 Guidance "We have raised our guidance for this year's earnings per share by $0.05 to reflect the accretion from our share repurchase program and adjusted the share count," said Ruiz-Comas. "All of our other performance metrics are tracking our prior expecta...

Duane Reade Holdings, Inc. Reports First Quarter 2009 Results

...in July 2011. (7) The increase in the balance of the redeemable preferred stock and accrued dividends from December 27, 2008 is due to the accretion of the discount on the liability recorded for the preferred stock offering completed during the second quarter of 2007 and the ...
accretion in Medical Technology

Pharmasset Reports Fiscal Year End 2008 Financial Results

... - - NET LOSS (54,657,711) (5,064,648) (11,325,657) REDEEMABLE PREFERRED STOCK accretion - 1,775,684 1,110,973 NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS $(54,657,711) $(6,8...

Pharmasset Reports Financial Results for Quarter Ended June 30, 2008

... -------------------------- NET LOSS (15,028,443) (5,862,113) REDEEMABLE PREFERRED STOCK accretion - 1,204,653 -------------------------- NET LOSS ATTRIBUTABLE TO COMMON STOC...

Amicus Therapeutics Announces Second Quarter 2008 Financial Results

...n expense -- Pre-tax charges for preferred stock accretion -- Pre-tax charges for changes in the fair value... - - (19,424) Preferred stock accretion (310) - (351) - ...k GAAP as Non-GAAP accretion Compensation Reported Income Statement Clas...

Pharmasset Reports First Fiscal Quarter 2008 Financial Results

... ------------------------------ NET INCOME (LOSS) (12,172,599) 3,907,206 REDEEMABLE PREFERRED STOCK accretion - 284,197 ------------------------------ NET INCOME (...

Vanda Pharmaceuticals Reports Third Quarter 2007 Results

...ock- based compensation 14,480,108 4,525,202 Loss on disposal of assets 27,017 29,528 accretion of discount on investments (1,315,609) (301,293) Changes in assets and liabilities: Prepaid expenses and other current assets ...

Amicus Therapeutics Announces Second Quarter 2007 Financial Results

...4) - (19,424) Preferred stock accretion (41) (310) (81) (351) ...as Non-GAAP Liability accretion sation Reported Income Statement Classificati...6) (86) Preferred stock accretion - (310) (310) ...
accretion in Medical Products

Healos Bone Graft Replacement

Description:... Healos is an osteoconductive matrix constructed of cross-linked collagen fibers that are fully coated with hydroxyapatite through a proprietary 360 accretion process. When combined with autogenous bone marrow aspirate, Healos provides an excellent environment for osteoprogenitor cell attachment, proliferati...
Company:DePuy Orthopaedics, Inc.
accretion in Medical Dictionary

Gallstone

... In medicine, gallstones (choleliths) are crystalline bodies formed within the body by accretion or concretion of normal or abnormal bile components. Overview, symptoms, diagnosis, and treatment of gallstones . Overview of the diseas...

Gallstones

... In medicine, gallstones (choleliths) are crystalline bodies formed within the body by accretion or concretion of normal or abnormal bile components. Overview, symptoms, diagnosis, and treatment of gallstones . WebMD looks at the caus...

Gall Stones

... In medicine, gallstones (choleliths) are crystalline bodies formed within the body by accretion or concretion of normal or abnormal bile components. Learn about gallstones symptoms like biliary colic, constant pain in the middle ... The...

Gallbladder

...en ... Although loss of the gallbladder impairs the efficiency of digestion, an ... Offers basic information on the crystalline bodies formed by accretion or ... If the gallbladder is inflamed, the patient will abruptly stop inhaling due to ... ...

Cholelithiasis

... Offers basic information on the crystalline bodies formed by accretion or concretion of normal or abnormal ... Cholelithiasis at eMedicine see Clinical Section ... Kidney cyst with gallstones, CT scan. Cholelit...
accretion in Biological News

Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results

... 32 72 47 Interest expense, including amortization of loan discount, deferred financing costs and accretion of beneficial conversion feature (280) (234) (1,508) (1,253) Preferred dividends (20) ¿ ...

February 2009 Geology and GSA Today media highlights

...hesis. Integration of this stratum into the Neoproterozoic record of climate change also places constraints on the timing of basin formation and early accretion in Central Asia. Tails of two plume types in one mantle A. Lenardic and A.M. Jellinek, Department of Earth Science, MS 126, P.O. Box 1892, Rice...

January GEOLOGY media highlights

...e. Repeated cycles of erosion around the rocks and subsequent rolling cause them to move and organize spatially. Evidence for focused magmatic accretion at segment centers from lateral dike injections captured beneath the Red Sea rift in Afar Derek Keir et al., School of Earth and Environment, Univ...

September Geology and GSA Today media highlights

... Building, Chester Street, Manchester M1 5GD, UK. Pages 691-694. Perry et al.'s study presents a long-term (approximately 1200 year) record of reef accretion and coral community composition from a turbid-zone, nearshore reef on the inner shelf of the Great Barrier Reef, Australia, and examines long-term int...

'Punctuated' evolution in the human genome

...plicated DNA sequences ?but only at specific time-points during evolution. It appears that long periods of genomic stasis, at least with regard to the accretion of duplicated DNA fragments, are "punctuated" by relatively brief episodes of duplicative activity. This is the first time that such temporal bias has...
accretion in Biological Technology

OncoGenex Reports Second Quarter 2009 Financial Results

...- ------------------ Net loss 4,563 2,168 6,972 3,825 Redeemable convertible preferred share accretion - 780 - 1556 ------------------ ------------------ Loss attributa...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results

... (13,623) (17,024) (26,095) (190,283) Deemed dividend - - - - (19,424) Preferred stock accretion - - - - (802) Net loss attributable to common stockholders $(9,294) $(13,623) $...

Vasogen Announces Second Quarter 2009 Results

...tes payable - - - - (1,279) accretion in carrying value of senior convertible notes payable ...f patents - - (487) - (487) accretion in carrying value of senior convertible...

Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results

... Total other income (expense) (229) 770 6,009 Net loss (19,303) (23,214) (219,478) accretion to redemption value of redeemable convertible preferred stock - - (78) Deemed dividend of b...

OncoGenex Reports First Quarter Financial Results

... (10) 214 Net loss 2,409 1,657 Redeemable convertible preferred share accretion - 776 ------------------------- Loss attributable to com...

Vasogen Announces First Quarter 2009 Results

...onvertible notes payable - - (1,279) accretion in carrying value of senior convertible notes payable ...in on sale of patents (487) - (487) accretion in carrying value of senior convertible notes payable ...

Gen-Probe Completes Acquisition of Tepnel Life Sciences

...robe, and (iii) the risk that Gen-Probe may not achieve its expected 2009 growth, revenue, earnings or other financial targets that are assumed in its accretion analysis. The foregoing list sets forth some, but not all, of the factors that could affect the Company's ability to achieve results described in any ...

OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009

... -------------------- Net loss 4,955 2,223 4,204 8,536 Redeemable convertible preferred share accretion - 788 1,973 2,944 -------------------- -------------------- Loss attributable to com...

Vasogen Announces 2008 Year-End Results

...otes payable - (5) (930) (1,279) accretion in carrying value of senior convertible notes payable ... equipment 125 - - 125 accretion in carrying value of senior convertible notes ...

Pharmacyclics Reports Second Quarter Fiscal 2009 Financial Results

...The principal amount of the loan has been discounted to fair value for balance sheet presentation as a result of the below market interest rates. The accretion of the discount will cause an increase in the carrying amount of indebtedness, and in charges to interest expense, from December 31, 2008 to June 30, ...
Other Tags
(Date:7/25/2014)... The new report “Carbohydrase Market by Applications (Food ... Type (Amylases, Cellulases, and Others), Source (Microorganisms, Animals, ... Forecasts to 2019", by MarketsandMarkets, identifies the driving ... with analysis of trends, opportunities, winning imperatives, and ... forecasted on the basis of major regions such ...
(Date:7/25/2014)... 25, 2014 In today’s technological era, ... and supporting devices. This benefits the organization in various ... cyber attacks which can destroy the confidential information and ... Risk and Compliance (EGRC) manage and protect the enterprise ... can cause loss in dollars to the comp may. ...
(Date:7/25/2014)... NY (PRWEB) July 25, 2014 ... injury law firm with over 25 years of ... stemming from dangerous prescription drugs, announces the launch ... offer information to those who believe they have ... , The site offers valuable information about the ...
(Date:7/25/2014)... The European liquid chromatography reagents report defines ... and forecast of revenue. The liquid chromatography reagents market ... 2013, and is estimated to grow to around $1581.8 ... from 2013 to 2018. , Browse through the TOC ... an idea of the in-depth analysis provided. This also ...
(Date:7/25/2014)... the vast majority of adults finish all of the food ... new study. This is true for adults from ... Cornell University revealed. They noted their findings could help ... make better choices. "If you put it on your ... director of the Cornell Food and Brand Lab, said in ...
Breaking Medicine News(10 mins):Health News:Carbohydrase Market worth $3,717.7 Million by 2019 - Report by MarketsandMarkets 2Health News:Carbohydrase Market worth $3,717.7 Million by 2019 - Report by MarketsandMarkets 3Health News:Carbohydrase Market worth $3,717.7 Million by 2019 - Report by MarketsandMarkets 4Health News:North America Enterprise Governance, Risk, and Compliance Market is Expected to Reach $3,972.6 Million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Enterprise Governance, Risk, and Compliance Market is Expected to Reach $3,972.6 Million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Enterprise Governance, Risk, and Compliance Market is Expected to Reach $3,972.6 Million in 2018 - New Report by MicroMarket Monitor 4Health News:North America Enterprise Governance, Risk, and Compliance Market is Expected to Reach $3,972.6 Million in 2018 - New Report by MicroMarket Monitor 5Health News:North America Enterprise Governance, Risk, and Compliance Market is Expected to Reach $3,972.6 Million in 2018 - New Report by MicroMarket Monitor 6Health News:Rottenstein Law Group LLP Announces Launch of Xarelto Injury Website 2Health News:European Liquid Chromatography Reagents Market is Expected to Reach $1581.8 Million in 2018 - New Report by MicroMarket Monitor 2Health News:European Liquid Chromatography Reagents Market is Expected to Reach $1581.8 Million in 2018 - New Report by MicroMarket Monitor 3Health News:European Liquid Chromatography Reagents Market is Expected to Reach $1581.8 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Most Adults Are Members of 'Clean Plate Club' 2
(Date:7/24/2014)... 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") ... active control Phase 3 study of Zerenex (ferric citrate), ... the treatment of hyperphosphatemia in patients with end-stage renal ... and iRon delivery with FErric CiTrate in EsrD) was ... American Society of Nephrology ( JASN ). ...
(Date:7/24/2014)... numbers have decreased by 45% on average over a ... reports a study on the impact of humans on ... enormous benefits invertebrates such as insects, spiders, crustaceans, slugs ... and pest control for crops, decomposition for nutrient cycling, ... in Science and led by UCL, Stanford ...
(Date:7/24/2014)... the product of 3.5 billion years of evolutionary trial ... life. But it may be reaching a tipping point. ... analysis of data published in Science , an ... decline of animals is contributing to what appears to ... biological extinction event. , Since 1500, more than 320 ...
Breaking Biology News(10 mins):Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4Invertebrate numbers nearly halve as human population doubles 2Invertebrate numbers nearly halve as human population doubles 3Stanford biologist warns of early stages of Earth's 6th mass extinction event 2Stanford biologist warns of early stages of Earth's 6th mass extinction event 3
Other Contents